Hepatocyte-based gene therapy

Area of Science:

• Hepatology
• Gene Therapy
• Molecular Biology

Background:

• Hepatocyte-based gene therapy offers diverse applications including gene replacement and liver repopulation.
• Viral vectors are currently the most effective method for gene transfer into hepatocytes.
• Various viral vectors exist, including integrating (retroviruses, lentiviruses, adeno-associated virus) and episomal (adenoviruses).

Purpose of the Study:

• To review the current state and potential of hepatocyte-based gene therapy.
• To discuss methods for achieving massive liver repopulation using transplanted hepatocytes.
• To explore strategies for enhancing gene transfer efficiency and transgene persistence.

Main Methods:

• Utilizing viral vectors (retroviruses, lentiviruses, adeno-associated virus, adenoviruses, SV40) for gene transfer into hepatocytes.
• Employing strategies to inhibit host hepatocyte proliferation (plant alkaloids, irradiation).
• Implementing mitotic stimuli for transplanted hepatocytes (partial hepatectomy, Fas ligand, thyroid hormone).

Main Results:

• Viral vectors, particularly integrating types, are crucial for sustained gene expression.
• Hybrid vectors combining adenoviral efficiency with integrative capacity show promise.
• Simultaneous inhibition of host cell proliferation and stimulation of transplanted cell proliferation enables massive liver repopulation.

Conclusions:

• Hepatocyte gene therapy holds significant promise for treating liver diseases.
• Optimizing vector choice and proliferation control strategies are key to successful liver repopulation.
• Future research may focus on developing more efficient and safer gene delivery systems and therapeutic protocols.